A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER+ breast cancer.
Wang B, Ma M, Dai Y, Yu P, Ye L, Wang W, Sha C, Yang H, Yang Y, Zhu Y, Dong L, Wei S, Wang L, Tian J, Wang H.
Wang B, et al. Among authors: wang h, wang w, wang l.
Eur J Med Chem. 2024 Jan 15;264:115934. doi: 10.1016/j.ejmech.2023.115934. Epub 2023 Nov 8.
Eur J Med Chem. 2024.
PMID: 38007911